48 results
6-K
EX-99.1
h43h556b8ze bvcc8v5
29 Mar 19
Current report (foreign)
6:02am
6-K
EX-99.1
hzu8 wslv5cwggutks
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
mgg j15op
30 Nov 20
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
5:10pm
6-K
EX-99.1
mm6x5jgv3
25 May 23
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis
5:49pm
6-K
EX-99
4ssbz lm4i1y0
20 Oct 15
Form 6-K Filing Document
12:00am
6-K
EX-99
pk31w
20 Oct 15
Form 6-K Filing Document
12:00am
6-K
EX-99.1
5p5pu5
29 Mar 19
Current report (foreign)
6:00am
S-8
EX-99.3
51rw 7wu1y9
4 Dec 23
Registration of securities for employees
5:16pm